HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Figarella-Branger Selected Research

Neoplasms (Cancer)

12/2021The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches.
11/2021Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome.
6/2016[Immunohistochemical hormonal mismatch and human epidermal growth factor type 2 [HER2] phenotype of brain metastases in breast cancer carcinoma compared to primary tumors].
1/2016Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152.
7/2014[Necrotizing myopathies: From genetic to acquired forms].
6/2014Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice.
5/2014Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB.
8/2010KIAA0510, the 3'-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas.
2/2010[Publication of biological samples collections catalogues by tumor banks].
12/2008[Prognostic implications of biologic markers in intracranial meningiomas: 120 cases].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Figarella-Branger Research Topics

Disease

26Neoplasms (Cancer)
12/2021 - 01/2000
9Glioblastoma (Glioblastoma Multiforme)
11/2018 - 05/2001
7Muscular Diseases (Myopathy)
10/2015 - 06/2001
6Glioma (Gliomas)
12/2021 - 05/2001
6Astrocytoma (Pilocytic Astrocytoma)
07/2014 - 05/2001
5Oligodendroglioma
01/2020 - 05/2001
4Contracture
04/2016 - 09/2001
4Neoplasm Metastasis (Metastasis)
04/2001 - 01/2000
3Meningioma (Meningiomas)
11/2021 - 10/2000
3Malignant Hyperthermia
04/2016 - 06/2001
2Brain Neoplasms (Brain Tumor)
06/2016 - 06/2006
2Ependymoma
01/2008 - 12/2007
2Myositis (Idiopathic Inflammatory Myopathies)
02/2005 - 10/2001
2Macrophagic myofasciitis
10/2002 - 05/2001
2Myalgia
03/2002 - 06/2001
1Noma (Nomas)
11/2021
1Monosomy
01/2020
1Breast Neoplasms (Breast Cancer)
06/2016
1Carcinoma (Carcinomatosis)
06/2016
1Heat Stroke (Heatstroke)
04/2016
1Cardiomyopathies (Cardiomyopathy)
10/2015
1Hereditary Myopathy with Early Respiratory Failure
10/2015
1Distal Myopathies (Distal Muscular Dystrophy)
10/2015
1Myofibrillar Myopathy
10/2015
1Connective Tissue Diseases (Connective Tissue Disease)
07/2014
1Carcinogenesis
10/2013
1Ganglioglioma
08/2010
1Respiratory Insufficiency (Respiratory Failure)
04/2008
1Glycogen Storage Disease Type II (Pompe's Disease)
04/2008
1Prostatic Neoplasms (Prostate Cancer)
01/2008
1Medulloblastoma
12/2007

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2015 - 03/2001
5AntibodiesIBA
06/2008 - 10/2000
4VimentinIBA
08/2007 - 10/2000
4Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
09/2002 - 01/2000
3Creatine Kinase (Creatine Phosphokinase)IBA
07/2014 - 05/2006
3polysialyl neural cell adhesion moleculeIBA
04/2006 - 01/2000
2ParaffinIBA
12/2021 - 06/2016
2Estrogen ReceptorsIBA
06/2016 - 12/2008
2Biomarkers (Surrogate Marker)IBA
06/2016 - 12/2008
2Progesterone Receptors (Progesterone Receptor)IBA
06/2016 - 12/2008
2Messenger RNA (mRNA)IBA
06/2014 - 08/2010
2Biological ProductsIBA
02/2010 - 12/2008
2AcidsIBA
04/2008 - 02/2001
2Protons (Proton)IBA
12/2007 - 03/2007
2AntigensIBA
04/2006 - 02/2001
2Temozolomide (Temodar)FDA LinkGeneric
07/2005 - 05/2001
2CalpainIBA
04/2005 - 01/2002
2Capsules (Microcapsules)IBA
06/2004 - 01/2000
2FluoroquinolonesIBA
03/2002 - 06/2001
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2001 - 03/2000
1Formaldehyde (Formol)FDA Link
12/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2021
1nomegestrol acetateIBA
11/2021
1Cyproterone AcetateIBA
11/2021
1Progestins (Progestagens)IBA
11/2021
1Chlormadinone Acetate (Chlormadinone)IBA
11/2021
1Pharmaceutical PreparationsIBA
11/2021
1A-Form DNA (A-DNA)IBA
01/2020
1beta CateninIBA
11/2018
1fluorodopa F 18IBA
08/2017
1Amino AcidsFDA Link
08/2017
1Epidermal Growth Factor (EGF)IBA
06/2016
1ErbB Receptors (EGF Receptor)IBA
06/2016
1MED 27IBA
06/2016
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
04/2016
1GDC-0152IBA
01/2016
1Inhibitor of Apoptosis ProteinsIBA
01/2016
1ConnectinIBA
10/2015
1DesminIBA
10/2015
1Reticulin (Reticular Fiber)IBA
07/2014
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
07/2014
1AutoantibodiesIBA
07/2014
1Fibronectins (Fibronectin)IBA
06/2014
1Mitogen-Activated Protein KinasesIBA
10/2013
1tenascin RIBA
08/2010
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2008
1Cathepsin DIBA
12/2008
1Thymidine KinaseIBA
12/2008
1Cystatin CIBA
12/2008
1Cystatin BIBA
12/2008
1Cathepsin BIBA
12/2008
1Cystatin AIBA
12/2008
1Plasminogen InactivatorsIBA
12/2008
1Cathepsin LIBA
12/2008
1alpha-Glucosidases (Acid Maltase)IBA
04/2008
1AndrogensIBA
01/2008
1AdrenomedullinIBA
01/2008
1Chromogranin AIBA
01/2008
1CreatineIBA
12/2007
1gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
08/2007
1Intermediate Filament ProteinsIBA
08/2007
1Transcription Factors (Transcription Factor)IBA
08/2007

Therapy/Procedure

8Radiotherapy
01/2008 - 04/2001
4Therapeutics
11/2018 - 01/2000
2Intraperitoneal Injections
01/2008 - 02/2001
2Transplantation
06/2006 - 11/2003
2Drug Therapy (Chemotherapy)
07/2005 - 05/2001
1Noninvasive Ventilation
04/2008
1Aftercare (After-Treatment)
01/2008